Heterodinucleoside phosphates of 5-Fluorodeoxyuridine and Arabinofuranosylcytosine - New drugs in cancer chemotherapy?

Philipp Saiko, Zsuzsanna Horvath, Walter Jaeger, Herbert Schott, Monika Fritzer-Szekeres, Thomas Szekeres

    Veröffentlichungen: Beitrag in FachzeitschriftArtikelPeer Reviewed

    Abstract

    The incidence of cancer is rapidly increasing and malignancies have become the number two cause of deaths in the Western world after cardiovascular diseases. In particular, colon cancer represents one of the most frequent types of malignancy. Chemotherapy is, in addition to surgery and irradiation, still one of the main treatment options against this group of diseases. Here, several chemotherapeutic treatment modalities and anticancer compounds for the treatment of colon cancer are reviewed. In particular, a newer group of heterodinucleoside phosphates (dimers), consisting of two well known antimetabolites (5-FdUrd (5-Fluorodeoxyuridine) and Ara-C (Cytarabine)), are presented. These dimers were evaluated in several studies and might offer an additional option for the treatment of various malignancies, in particular colon carcinomas. The results are summarized in detail, as these dimers might have some significant advantages when compared with conventional regimens; they might be administered orally and might constitute an alternative treatment option for resistant tumors.

    OriginalspracheEnglisch
    Seiten (von - bis)205-214
    Seitenumfang10
    FachzeitschriftIN VIVO
    Jahrgang19
    Ausgabenummer1
    PublikationsstatusVeröffentlicht - 1 Jan. 2005

    ÖFOS 2012

    • 301207 Pharmazeutische Chemie

    Fingerprint

    Untersuchen Sie die Forschungsthemen von „Heterodinucleoside phosphates of 5-Fluorodeoxyuridine and Arabinofuranosylcytosine - New drugs in cancer chemotherapy?“. Zusammen bilden sie einen einzigartigen Fingerprint.

    Zitationsweisen